Spine, joint replacement and now musculoskeletal tumour - Gleneagles Hospital Hong Kong launched its third specialty centre on 24 September to deal with complex malignant tumours that originate in bone or soft tissues such as the muscle and cartilage.
A multidisciplinary team is set up to provide proper diagnosis and treatment to this disease that is often neglected due to low public awareness.
Statistics from the Hong Kong Cancer Registry show that malignant musculoskeletal tumours are uncommon, with only about 250 new cases per year. As a result, public awareness is low and the risk of misdiagnosis is high and may worsen with lack of proper surgery and treatment.
Without proper image scanning and pathological examinations, musculoskeletal tumours can be easily misdiagnosed. A hastily planned surgery without concrete diagnosis also exposes the patient to unnecessary risks, including the possible spread of tumour cells during surgery. This could increase the complexity of subsequent surgeries, and may even require amputation due to lack of proper treatment or affect patients’ survival rates."
- Dr Timothy So, Director of the Musculoskeletal Tumour Centre and Honorary Consultant in Orthopaedics & Traumatology at Gleneagles Hong Kong Hospital
Related Stories
Future of Work: AI Agents in Action Hackathon Highlights AI Solutions for Healthcare and Business Challenges
The Future of Work: AI Agents in Action Hackathon invited colleagues from across the IHH network to explore how AI agents can help solve everyday challenges in healthcare and business operations.
Gleneagles Hong Kong Champions Health and Wellness at Hong Kong Cyclothon
IHH Healthcare's Gleneagles Hospital Hong Kong supported the 2026 Hong Kong Cyclothon as the event's Official Wellness Partner, helping promote active living and community wellbeing while providing medical support for one of the city's largest mass participation sporting events.
Pantai Hospital Kuala Lumpur Completes First Iberis® RDN Transradial Procedure Across Pantai Hospitals Group
Pantai Hospital Kuala Lumpur has achieved a cardiovascular care milestone with the successful completion of the first Iberis® renal denervation (RDN) transradial procedure within the Pantai hospital network.
Fortis Expands Advanced Respiratory Care with Dedicated Lung Failure Clinics
Fortis Healthcare, part of IHH Healthcare, is strengthening respiratory and transplant care in Delhi through new multidisciplinary Lung Failure Clinics.
Acibadem Advances Cancer Care with Türkiye’s First Private Proton Therapy Programme
Acibadem Healthcare Group, part of IHH Healthcare, is introducing cutting-edge proton therapy in Istanbul to deliver more precise, patient-centred cancer treatment and strengthen regional oncology expertise.
IHH Healthcare Wins Four Awards for Leadership and Learning Excellence
IHH Healthcare has been recognised at the 2026 HCM Excellence Awards® by Brandon Hall Group™ for four innovative programmes in leadership and learning. The awards showcase our commitment to strengthening capability, fostering collaboration and advancing a culture of safety and integrity across its global network.
